Hyper-CVAD Plus Ofatumumab as Frontline Therapy for Adults with CD20 Positive Acute Lymphoblastic Leukemia

Yilmaz Musa; Kantarjian Hagop; Ravandi Farhad; Thomas Deborah; Khouri Maria; Garcia-Manero Guillermo; Garris Rebecca; Cortes Jorge; Short Nicholas; Sasaki Koji; Issa Ghayas; Koller Paul; Schroeder Heather; Kadia Tapan; Verstovsek Srdan; Daver Naval; Jain Nitin; Konopleva Marina; OBrien Susan; Jabbour Elias

首页> 外文期刊>Clinical lymphoma, myeloma & leukemia >Hyper-CVAD Plus Ofatumumab as Frontline Therapy for Adults with CD20 Positive Acute Lymphoblastic Leukemia

【24h】

Hyper-CVAD Plus Ofatumumab as Frontline Therapy for Adults with CD20 Positive Acute Lymphoblastic Leukemia

机译：Hyper-cvad Plus ofatumumab作为CD20阳性急性淋巴细胞白血病成人的前线疗法

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical lymphoma, myeloma & leukemia》 |2019年第1期|共1页
作者
Yilmaz Musa; Kantarjian Hagop; Ravandi Farhad; Thomas Deborah; Khouri Maria; Garcia-Manero Guillermo; Garris Rebecca; Cortes Jorge; Short Nicholas; Sasaki Koji; Issa Ghayas; Koller Paul; Schroeder Heather; Kadia Tapan; Verstovsek Srdan; Daver Naval; Jain Nitin; Konopleva Marina; OBrien Susan; Jabbour Elias;
展开▼
作者单位

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

Univ Calif Irvine Chao Family Comprehens Canc Ctr Orange CA 92668 USA;

Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
ofatumumab; hyper-CVAD; ALL; CD20; survival; ALL; acute lymphoblastic leukemia;

机译：Ofatumumab;Hyper-CVAD;全部;CD20;生存;全部;急性淋巴细胞白血病;

相似文献

外文文献
中文文献
专利

1. Hyper-CVAD Plus Ofatumumab as Frontline Therapy for Adults with CD20 Positive Acute Lymphoblastic Leukemia [J] . Yilmaz Musa, Kantarjian Hagop, Ravandi Farhad, Clinical lymphoma, myeloma & leukemia . 2019,第Suppla1期

机译：Hyper-cvad Plus ofatumumab作为CD20阳性急性淋巴细胞白血病成人的前线疗法
2. A Phase II Study of the Hyper-CVAD Regimen in Sequential Combination with Blinatumomab As Frontline Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL) [J] . Richard-Carpentier Guillaume, Kantarjian Hagop M., Short Nicholas J., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：与Blinatumomab中的Hyper-CVAD方案与Blinatumomab作为B-Cell急性淋巴细胞白血病的前线治疗的II期研究（B-全部）
3. Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) Vs. Standard Intensive Chemotherapy (hyper-CVAD) As Frontline Therapy for Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL): A Propensity Score Analysis [J] . Sasaki Koji, Kantarjian Hagop M., Short Nicholas J., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：Inotuzumab ozogamicin与低强度化疗（迷你超级CVD）相结合。标准密集化疗（超CVAD）作为费城染色体阴性急性淋巴细胞白血病（ALL）的老年患者的前线治疗：倾向分数分析
4. Optimizing the Classification of Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia Samples using Artificial Neural Networks [C] . Nuannuan Zong, Malek Adjouadi, Melvin Ayala Annual Rocky Mountain Bioengineering Symposium . 2006

机译：利用人工神经网络优化急性淋巴细胞白血病和急性髓性白血病样品的分类
5. Induction of hypersignaling as a therapeutic approach for treatment of BCR-ABL1 positive Acute Lymphoblastic Leukemia (ALL) cells. [D] . Shojaee, Seyedmehdi. 2013

机译：诱导高信号作为一种治疗BCR-ABL1阳性急性淋巴细胞白血病（ALL）细胞的治疗方法。
6. First Report of a Phase II Prospective Study of Combination of Hyper-CVAD with Ponatinib in Frontline Therapy of Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [O] . Elias Jabbour, Hagop Kantarjian, Farhad Ravandi, -1

机译：Hyper-CVAD与Ponatinib联合用于费城染色体阳性急性淋巴细胞性白血病一线治疗的II期前瞻性研究的首次报道
7. Addition of rituximab to hyper-CVAD in the treatment of CD20-positive adult acute lymphocytic leukemia (ALL) [O] . Cumpston A., Weisenborn R., Ericson S. 2006

机译：在高CVAD中添加利妥昔单抗治疗CD20阳性的成人急性淋巴细胞白血病（ALL）

Hyper-CVAD Plus Ofatumumab as Frontline Therapy for Adults with CD20 Positive Acute Lymphoblastic Leukemia

著录项

相似文献

相关主题

期刊订阅